VFA
CASC

Valeo Financial Advisors’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Valeo Financial Advisors’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,000
Closed -$7K – 1643
2017
Q4 		$7K Hold
2,000
– – ﹤0.01% 944
2017
Q3 		$8K Buy
+2,000
New +$7.65K ﹤0.01% 777

Valeo Financial Advisors's CASC Position: Q1 2018 in Review

Valeo Financial Advisors sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 2,000 shares — an estimated $7K sold.

Valeo Financial Advisors first reported a position in CASC in Q3 2017 and held it in 2 quarters. The position peaked at $8K in Q3 2017. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

  • Valeo Financial Advisors reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Valeo Financial Advisors sold 2,000 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $7K.
  • Valeo Financial Advisors first reported a position in Cascadian Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Valeo Financial Advisors's Cascadian Therapeutics, Inc. position peaked at $8K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on Valeo Financial Advisors's 13F filing for Q1 2018, filed 12 Apr 2018.